WEX Inc.

WEX

CIK 0001309108 · Quarterly mode · latest period FY2026 (Q1) (ending 2026-03-31) · sourced from SEC EDGAR

At a glance · FY2026 (Q1)

Revenue
$674M
↑+5.8% +$37Mvs FY2025 (Q1)
Operating Income
$158M
↑+0.6% +$900Kvs FY2025 (Q1)
Net Income
$78M
↑+8.7% +$6Mvs FY2025 (Q1)
Gross Profit
$394M
↑+7.4% +$27Mvs FY2025 (Q1)

Quality Score

Quality score

6-dimension fundamental snapshot · latest annual filed values · S&P 500 calibration

Poor
20/100
  • Profitability
    26ROIC 10.3% (10% = solid, 20%+ = moat)
  • Liquidity
    27Current Ratio 1.05 (above 1.5 = solid)
  • Leverage
    0D/E 2.86 (under 0.5 = conservative)
  • Efficiency
    0Asset Turnover 0.19x (1.0+ = capital-efficient)
  • Growth
    36Revenue YoY +5.8% (10% = solid, 25%+ = elite)
  • Margin Trend
    28Op Margin 23.5% · trend -1.3pts (4Q avg vs prior 4Q)

Calibrated to S&P 500 medians. Each sub-score is computed from a single CFA-grade ratio (Profitability = ROIC, Liquidity = Current Ratio, Leverage = D/E, Efficiency = Asset Turnover, Growth = Revenue YoY, Margin Trend = 4Q operating-margin avg vs prior 4Q). Overall = simple mean.

DCF intrinsic value

DCF intrinsic value

two-stage Gordon model

Project WEX's free cash flow forward, discount back at your hurdle rate, divide by diluted shares. Edit the assumptions to see how sensitive the intrinsic value is.

3%

Trailing 3-yr CAGR was -25.7%

10%

10% is a common all-equity benchmark for US large-caps

2.5%

Should be ≤ long-run GDP growth (~2.5% nominal)

5

5-year explicit projection + perpetuity terminal

Intrinsic value per share
$121.99
Total enterprise IV
$4.38B
Diluted shares
0.04B
Terminal PV
$3.09B (70% of total)
Year-5 FCF
$364M
YearProjected FCFDiscounted PV
+1$323M$294M
+2$333M$275M
+3$343M$258M
+4$353M$241M
+5$364M$226M
Terminal$4.97B$3.09B

DCF outputs are HIGHLY sensitive to growth + WACC assumptions. A 1pp WACC change can shift IV by 20%+. Use this as a sanity-check vs market price, not a target — and always cross-check the underlying FCF source (EDGAR cashflow statement, latest annual). Margin of safety convention: 30-50% discount to IV before buying.

Capital allocation · trailing 4 quarters

how the company spent its cash
Capex (TTM)
$170M
investment in PP&E
Stock buybacks (TTM)
$100K
share count reduction
Stock-based comp (TTM)
$84M
non-cash dilution

Balance sheet · 2026-03-31

latest filed snapshot
Total assets
$15.43B
everything owned
Total liabilities
$14.15B
everything owed
Stockholders' equity
$1.27B
shareholder claim
Net debt
$2.97B
LT debt minus cash

Recent performance · 71 quarters

Revenue↑+5.8% +$37M
$674M
Net Income↑+8.7% +$6M
$78M
Free Cash Flow↓-260.1% -$598M
$-368M
Operating Margin↓-1.2pts
23.5%

Drill down